Aztron Medtech Corporation, a US-based orthopaedic device company, has announced that its Taiwan subsidiary, Astron Medtech, has received the Presidential Award, the highest honor presented through Taiwan's National Development Council (NDC) Startup Programme, together with a NT$10 million grand prize.
The award recognises the company's innovation and commercial achievements following a rigorous nine-month competition. Co-founder and CEO Yi-Hsi Huang delivered the company's final presentation, earning 1st place out of nearly 3,000 startups nationwide. The Presidential Award recognises companies demonstrating exceptional innovation, commercialisation potential, and economic impact.
Yi-Hsi Huang, CEO of Astron Medtech Co. said, "As we continue expanding adoption of the TendMIN® system across the United States, we remain committed to working alongside surgeons to bring next-generation minimally invasive orthopedic technology to more patients."
These recognitions reflect Aztron Medtech's continued commercial momentum in the United States, where the TendMIN® system has now surpassed 200 clinical procedures across US hospitals and surgical centres. Building on this milestone, the company continues to expand collaborations with leading surgeons, strengthen its commercial partnerships, and generate clinical evidence to support the broader adoption of minimally invasive Achilles tendon repair.
The company expects to pursue its next financing round later this year to support continued product development, commercial expansion, and international growth.
